Financial insights of CTNM

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development	11,648	12,687*	10,992	-
General and administrative	5,256	4,717*	3,940	-
Other segment items	-	-	-	167
Total operating expenses	16,904	17,404	14,932	-
Research and development-Unallocated Internal Costs	-	-	-	3,338
Loss from operations	-16,904	-17,404*	-14,932	-
Research and development-PIPE791	-	-	-	6,178
Interest income	2,505	892*	-	-
Research and development-PIPE307	-	-	-	2,160
Change in fair value of warrant liability	-	0*	-	-
Research and development-Discovery Programs	-	-	-	1,328
Other expense, net	-57	-41*	-	-
Research and development-CTX343	-	-	-	1,059
Total other income, net	2,448	851*	2,410	-
Interest income	-	-	-	2,029
Net loss	-14,456	-16,553*	-12,792	-
General and administrative	-	-	-	3,839
Unrealized loss (gain) on marketable securities	-513	-165*	118	-
Net loss	-	-	-	-16,040
Comprehensive loss	-14,969	-16,718	-12,674	-

Basic EPS	-0.39	-0.613	-0.45	-
Diluted EPS	-0.39	-0.604	-	-
Basic Average Shares	37,339,026	27,286,162	28,115,548	-
Diluted Average Shares	37,339,026	27,700,855	-	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.